Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide as First or Later Add-On in Partial-Onset Seizures
NCT00955357Phase 4Completed
- Sponsor
- UCB
- Start
- Aug 2009
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 15
01
Overview
Phase 4, open-label trial of lacosamide in focal onset seizure (2 arms), sponsored by UCB. Primary endpoint: Proportion of Subjects Who Achieved Seizure-free Status at 12 weeks. Started Aug 2009; status: completed.
02
Drugs
lacosamide
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT00955357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00955357.